Stocks & ETFs Screener: 96 results (Pharmaceuticals)
| Symbol | Industry | Market Cap | Fund. Score | Div. Score | Tech. Score | P/E | Return 12m vs S&P 500 |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly |
Pharmaceuticals
Insulin, Diabetes, Oncology |
918B | 84.1% | 70.2% | 68.4% | 50.0 | 26.7% |
| JNJ Johnson & Johnson |
Pharmaceuticals
Pharmaceuticals, Medical Devices |
470B | 80.2% | 61.6% | 59.4% | 18.9 | 20.5% |
| ZEG AstraZeneca |
Pharmaceuticals
Oncology, Respiratory |
276B | 79.6% | 41.9% | 48.7% | 29.5 | 17.6% |
| AZN AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
276B | 83.5% | 39.9% | 75.0% | 29.4 | 28.7% |
| NVS Novartis |
Pharmaceuticals
Cardiovascular,Oncology,Immunology,.. |
244B | 94.3% | 59.9% | 94.7% | 17.4 | 13.0% |
| MRK Merck |
Pharmaceuticals
Keytruda, Gardasil, Januvia |
231B | 85.3% | 66.3% | -3.32% | 12.3 | -9.65% |
| NVO Novo Nordisk |
Pharmaceuticals
Insulin, Obesity Medication |
221B | 89.1% | 69.6% | -38.6% | 13.6 | -57.6% |
| PFE Pfizer |
Pharmaceuticals
Vaccines, Antivirals, Oncology |
147B | 63.5% | 71.3% | -35.6% | 15.0 | -4.90% |
| SAN Sanofi |
Pharmaceuticals
Immunology, Oncology, Neurology |
127B | 65.0% | 64.2% | -0.72% | 17.1 | -11.7% |
| SNY Sanofi |
Pharmaceuticals
Vaccines, Oncology, Immunology |
124B | 63.2% | 56.0% | 30.4% | 16.7 | -3.86% |
| BMY Bristol-Myers |
Pharmaceuticals
Oncology, Hematology, Immunology |
99.0B | 76.9% | 61.0% | -60.6% | 15.7 | -25.8% |
| GSK GlaxoSmithKline |
Pharmaceuticals
Vaccines, Specialty Medicines |
95.5B | 79.6% | 28.7% | 79.1% | 13.5 | 30.0% |
| GS71 GSK |
Pharmaceuticals
Vaccines, Specialty Medicines |
95.5B | 78.5% | 21.8% | 57.1% | 13.6 | 19.5% |
| MRK Merck KGaA |
Pharmaceuticals
Reagents, Drugs, Pigments |
59.2B | 61.3% | 38.5% | -67.0% | 17.8 | -26.4% |
| ZTS Zoetis |
Pharmaceuticals
Vaccines, Parasiticides |
52.4B | 88.0% | 69.1% | -51.1% | 19.9 | -37.7% |
| TAK Takeda |
Pharmaceuticals
Gastroenterology, Oncology, Rare |
45.1B | 60.1% | 36.4% | 29.6% | 204 | -0.13% |
| BAYN Bayer NA |
Pharmaceuticals
Pharmaceuticals, Consumer Health |
34.1B | 49.0% | 1.0% | -3.56% | - | 26.4% |
| TEVA Teva Pharma |
Pharmaceuticals
Generic Drugs, CNS Therapies |
30.2B | 52.4% | 18.1% | 71.4% | 41.9 | 26.2% |
| RPRX Royalty Pharma |
Pharmaceuticals
Royalties, Rare Disease, Cancer |
22.9B | 54.9% | 71.8% | 27.8% | 22.7 | 34.5% |
| IPN Ipsen |
Pharmaceuticals
Oncology, Neuroscience, Rare |
12.6B | 89.0% | 49.6% | 48.5% | 24.5 | 6.55% |
| VTRS Viatris |
Pharmaceuticals
Brand, Generic, Biosimilar |
12.6B | 31.6% | 64.9% | -13.8% | - | -26.4% |
| RDY Dr. Reddy’s |
Pharmaceuticals
Generics, APIs, Biologics |
11.6B | 81.7% | 48.6% | 35.6% | 17.6 | -11.0% |
| ELAN Elanco Animal |
Pharmaceuticals
Parasiticides, Vaccines |
10.9B | 45.6% | - | 56.9% | 314 | 47.8% |
| JAZZ Jazz |
Pharmaceuticals
Xywav, Xyrem, Epidiolex, Rylaze |
8.61B | 50.6% | - | 5.90% | - | 25.9% |
| CORT Corcept |
Pharmaceuticals
Hyperglycemia, Cushings |
7.97B | 68.0% | - | 87.4% | 86.8 | 23.0% |
| AXSM Axsome Therapeutics |
Pharmaceuticals
Antidepressant, Wake-Promoting |
6.93B | 33.5% | - | 79.3% | - | 35.5% |
| AMRX Amneal |
Pharmaceuticals
Generics, Injectables |
3.66B | 70.0% | - | 79.7% | - | 27.8% |
| VIRP Virbac |
Pharmaceuticals
Vaccines, Antibiotics |
3.46B | 86.7% | 57.9% | 55.4% | 22.5 | -0.25% |
| TARS Tarsus |
Pharmaceuticals
Eyelash Mite Therapy, Ocular |
3.08B | 38.2% | - | 71.2% | - | 52.8% |
| PBH Prestige Brand |
Pharmaceuticals
Analgesic, Diaper, Throat, Eye |
2.89B | 64.0% | 0.21% | -17.8% | 14.9 | -37.2% |
| SUPN Supernus |
Pharmaceuticals
ADHD, Epilepsy, Parkinson |
2.62B | 47.4% | - | 42.6% | - | 12.6% |
| BHC Bausch Health |
Pharmaceuticals
Gastroenterology, Dermatology |
2.56B | 51.7% | 4.23% | -38.0% | 6.47 | -34.4% |
| OCUL Ocular Therapeutix |
Pharmaceuticals
Dexamethasone, Axitinib, Travoprost |
2.38B | 27.3% | - | 72.2% | - | 27.9% |
| LQDA Liquidia |
Pharmaceuticals
Dry Powder Injectable Liposomal |
2.37B | 26.1% | - | 93.6% | - | 155% |
| DMP Dermapharm Holding |
Pharmaceuticals
Branded Generics, OTC |
2.10B | 72.9% | 49.9% | -37.8% | 16.9 | -14.5% |
| OGN Organon |
Pharmaceuticals
Contraception, Fertility |
1.98B | 61.0% | 50.9% | -85.3% | 3.94 | -55.9% |
| HRMY Harmony |
Pharmaceuticals
Wakix, Pitolisant, BP1.15205 |
1.96B | 91.7% | - | -39.7% | 10.7 | -8.11% |
| PRGO Perrigo |
Pharmaceuticals
OTC, Vitamins, Infant Formula |
1.92B | 44.1% | 74.1% | -78.3% | - | -56.6% |
| ANIP ANI Pharmaceuticals |
Pharmaceuticals
Injectables, Softgels, Cortrophin |
1.90B | 68.2% | - | 93.3% | 52.8 | 27.0% |
| AVDL Avadel |
Pharmaceuticals
Sodium Oxybate, Narcolepsy |
1.88B | 63.9% | - | 79.0% | - | 75.8% |
| TERN Terns |
Pharmaceuticals
TKI, THR-Agonist, GLP-1-Agonist |
1.87B | 32.3% | - | 58.9% | - | 310% |
| PAHC Phibro Animal |
Pharmaceuticals
Antibacterials, Vaccines |
1.81B | 61.8% | 37.0% | 82.2% | 26.8 | 58.8% |
| INVA Innoviva |
Pharmaceuticals
Inhaled Combo, Vasoconstrictor |
1.66B | 86.5% | 2.39% | 62.0% | 13.4 | -2.13% |
| EVT Evotec SE |
Pharmaceuticals
Oncology, Autoimmune, Metabolic |
1.47B | 22.8% | - | -82.2% | - | -54.0% |
| COLL Collegium |
Pharmaceuticals
Stimulant, Buccal, Opioid |
1.47B | 81.7% | - | 77.3% | 28.2 | 32.1% |
| HROW Harrow Health |
Pharmaceuticals
Antibiotic, Steroid |
1.40B | 44.7% | - | 60.0% | - | -21.1% |
| TRVI Trevi Therapeutics |
Pharmaceuticals
Chronic Cough, Nalbuphine |
1.40B | 32.1% | - | 91.9% | - | 258% |
| AMLX Amylyx |
Pharmaceuticals
Avexitide, Amx0035, Amx0114 |
1.39B | 21.4% | - | -5.43% | - | 152% |
| ELVN Enliven |
Pharmaceuticals
Kinase Inhibitor, HER2 Inhibitor |
1.31B | 28.4% | - | -5.35% | - | -23.8% |
| NKTR Nektar Therapeutics |
Pharmaceuticals
Treg Stimulator, PEG-CSF1, TNFR2 |
1.21B | 31.1% | - | 25.3% | - | 219% |
| AMPH Amphastar P |
Pharmaceuticals
Injectable, Inhalation |
1.21B | 73.6% | - | -26.9% | 11.7 | -48.0% |
| XERS Xeris |
Pharmaceuticals
Glucagon, Cortisol, Paralysis |
1.20B | 62.5% | - | 86.0% | - | 100.0% |
| WVE Wave Life Sciences |
Pharmaceuticals
RNA Editing, GalNAc-Conjugated |
1.18B | 29.3% | - | 1.21% | - | -56.3% |
| RAPP Rapport |
Pharmaceuticals
Antiepileptic, Analgesic |
1.18B | 31.2% | - | 43.1% | - | 7.69% |
| TLRY Tilray |
Pharmaceuticals
Cannabis,Beverage,Wellness,Distribu.. |
1.16B | 44.3% | - | -59.3% | - | -38.5% |
| PCRX Pacira BioSciences |
Pharmaceuticals
EXPAREL, ZILRETTA, Iovera |
1.02B | 61.8% | - | -32.9% | 50.6 | 18.0% |
| PHAT Phathom |
Pharmaceuticals
GERD,Heartburn,H.Pylori,Esophagitis |
977M | 65.8% | - | 43.8% | - | 41.3% |
| SEPN Septerna, Common |
Pharmaceuticals
GPCR, Oral, Small-Molecule |
971M | 46.1% | - | 37.0% | - | 4.40% |
| EYPT Eyepoint |
Pharmaceuticals
Therapeutics, Retinal, Durasert |
959M | 27.3% | - | 68.9% | - | 45.8% |
| CRON Cronos |
Pharmaceuticals
Dried Flower, Pre-Roll, Oil |
950M | 49.7% | - | -0.51% | 22.6 | 2.89% |
| TBPH Theravance |
Pharmaceuticals
COPD, Nebulizer, Ampreloxetine |
910M | 50.7% | - | 66.5% | 31.5 | 71.1% |
| ARVN Arvinas |
Pharmaceuticals
PROTAC, Cancer, Breast, Prostate |
847M | 40.6% | - | -74.2% | - | -59.2% |
| CRMD CorMedix |
Pharmaceuticals
Antimicrobial, Catheter, Solution |
790M | 93.8% | - | 51.3% | 4.54 | -16.6% |
| VTYX Ventyx Biosciences |
Pharmaceuticals
VTX958, Tamuzimod, VTX2735 |
682M | 35.7% | - | -13.6% | - | 385% |
| AQST Aquestive |
Pharmaceuticals
Epinephrine Film, Apomorphine |
647M | 54.9% | - | 70.4% | - | 12.9% |
| MAZE Maze Therapeutics |
Pharmaceuticals
Precision Medicine, APOL1 |
525M | 23.0% | - | 90.9% | - | 106% |
| EOLS Evolus |
Pharmaceuticals
Botulinum Toxin, Hyaluronic Acid |
478M | 26.0% | - | -34.6% | - | -53.3% |
| FULC Fulcrum |
Pharmaceuticals
Pociredir, Losmapimod, Fetal |
476M | 23.2% | - | 50.1% | - | 238% |
| ETON Eton |
Pharmaceuticals
Hormone, Enzyme, Metabolic |
453M | 52.2% | - | 79.3% | - | 36.3% |
| NMRA Neumora |
Pharmaceuticals
Kappa Antagonist, Agitation Drug |
449M | 44.5% | - | -64.1% | - | -78.6% |
| SNDL SNDL |
Pharmaceuticals
Cannabis, Liquor, Pre-Rolls |
436M | 50.2% | - | -33.5% | - | -27.6% |
| SIGA SIGA Technologies |
Pharmaceuticals
Antiviral, Smallpox, TPOXX, Health |
435M | 83.5% | 88.7% | 17.1% | 5.83 | -8.46% |
| ANRO Alto Neuroscience |
Pharmaceuticals
Bipolar Depression, Major |
429M | 43.1% | - | -14.3% | - | 188% |
| OMER Omeros |
Pharmaceuticals
Narsoplimab, OMS1029, Zaltenibart |
427M | 37.4% | - | 20.0% | - | 2.12% |
| CGC Canopy Growth |
Pharmaceuticals
Dried Flower, Extracts, Edibles |
405M | 18.3% | - | -83.6% | - | -74.4% |
| CTNM Contineum |
Pharmaceuticals
PIPE-791, PIPE-307, CTX-343 |
318M | 30.5% | - | -50.3% | - | -32.1% |
| RLMD Relmada |
Pharmaceuticals
Controlled-Release, Formulation |
290M | 44.9% | - | 9.37% | - | 38.2% |
| AARD Aardvark |
Pharmaceuticals
ARD-101, ARD-201, Obesity |
284M | 25.5% | - | -50.5% | - | -40.0% |
| BIOA BioAge Labs |
Pharmaceuticals
Azelaprag, BGE-102, Obesity |
280M | 51.6% | - | -53.5% | 0.57 | -58.3% |
| ACB Aurora Cannabis |
Pharmaceuticals
Dried Cannabis, Cannabis Oil |
256M | 63.3% | - | -37.7% | - | -12.9% |
| ACRS Aclaris |
Pharmaceuticals
JAK Inhibitor, TSLP Antibody |
251M | 29.5% | - | -66.9% | - | -48.3% |
| TVRD Tvardi |
Pharmaceuticals
Oral, STAT3, Inhibitor, Phase-2 |
242M | 59.6% | - | -60.0% | - | -68.7% |
| AVIR Atea |
Pharmaceuticals
Antiviral, Oral, Hepatitis |
239M | 41.7% | - | -41.6% | - | -18.7% |
| ALTS ALT5 Sigma |
Pharmaceuticals
Trading, Payments, Tokenization |
239M | 26.9% | 1.0% | -12.8% | - | -29.2% |
| MDWD Mediwound |
Pharmaceuticals
Eschar,Burn,Therapy,Tissue,Biopharm.. |
229M | 34.2% | - | 21.9% | - | -9.41% |
| OGI OrganiGram Holdings |
Pharmaceuticals
Cannabis,Flower,Pre-Rolls,Vapes,Edi.. |
208M | 41.3% | - | -35.8% | 155 | -12.8% |
| MIST Milestone |
Pharmaceuticals
Etripamil, Calcium Channel |
161M | 24.5% | - | -35.9% | - | 15.5% |
| ELTX Elicio Therapeutics |
Pharmaceuticals
Vaccine, Lymph Node, Preclinical |
151M | 50.3% | - | 18.9% | - | 46.9% |
| SAVA Cassava Sciences |
Pharmaceuticals
Simufilam, SavaDx |
142M | 32.9% | 0.17% | -63.2% | - | -92.1% |
| IRD Opus Genetics |
Pharmaceuticals
Gene Therapy, Retinal Disease |
120M | 37.7% | - | -7.65% | - | 72.7% |
| SCLX Scilex Holding |
Pharmaceuticals
Lidocaine, Migraine, Anti-Gout |
118M | 64.9% | - | -45.1% | - | 3.69% |
| TELO Telomir |
Pharmaceuticals
Small Molecule, Degenerative |
44.7M | 42.5% | - | -94.1% | - | -74.5% |
| MIRA MIRA |
Pharmaceuticals
Ketamine Analog, Marijuana Capsule |
30.4M | 39.8% | - | -17.0% | - | -1.82% |
| ITRM Iterum Therapeutics |
Pharmaceuticals
Oral Penem, Intravenous Penem, UTI |
26.9M | 34.0% | - | -90.1% | - | -80.6% |
| ASBP Aspire BioPharma |
Pharmaceuticals
Sublingual, Aspirin, Melatonin |
20.2M | 34.7% | - | -81.3% | - | -99.2% |
| CTXR Citius |
Pharmaceuticals
Immunotherapy, Antibiotic |
19.8M | 35.1% | - | -83.2% | - | -75.4% |